Understanding emotion processing in schizophrenia. Evidence from behavior, neuroimaging and imaging genetics
PhD ceremony: Ms. M. Swart, 11.00 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: Understanding emotion processing in schizophrenia. Evidence from behavior, neuroimaging and imaging genetics
Promotor(s): prof. A. Aleman and prof. D. Wiersma
Faculty: Medical Sciences
Emotional deficits are one of the core features of schizophrenia. Performance on emotional tasks is related amongst others to social and professional functioning. The aim of this thesis was to get a better understanding of emotion processing in schizophrenia and its underlying neural mechanisms. Therefore we investigated various emotional processes in patients with schizophrenia and non-psychotic first-degree relatives as they partly share the genetic vulnerability to develop a psychosis. We also investigated if a certain variant of the COMT gene (COMTVal158Met) influences emotion processing and its underlying neural mechanisms. We demonstrated that during reappraising negative events, patients showed decreased brain activation in areas important for emotion regulation. Also, patients had less connectivity between brain structures during learning and associating emotional pictures and words. This is consistent with the reported difficulties in regulating their emotions. Relatives reported less difficulties in emotion regulation than patients, but more than healthy control subjects. With regard to the COMT gene, individuals with the Met allele reported increased difficulties in regulating emotions. Additionally, they showed decreased brain activation in an area important for emotional awareness during valence evaluation of words. Finally, emotion regulation seems to be taken into account for treatment. In addition, it should be investigated whether individuals at high-risk might benefit from training in emotion regulation.
Last modified: | 13 March 2020 01.11 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.